US Patent Issued to bioMerieux on May 12 for "Assays for TIMP2 having improved performance in biological samples" (California, Washington Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,121, issued on May 12, was assigned to bioMerieux Inc. (Salt Lake City).

"Assays for TIMP2 having improved performance in biological samples" was invented by Ravi A. Vijayendran (San Diego) and Srivatsa Venkatasubbarao (Sammamish, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibodies or antigen binding fragments thereof that binds to human "TIMP2. Further provided are methods for treating subjects, including human subjects, in need of treatment with the isolated TIMP2 antibodies or antigen-binding fragments thereof disclosed herein. Further provided are pharmaceutical or sterile compositions of anti-TIMP2 an...